MK

Muskan Karamchandani

Active Director Director DIN 05237122
DIN 05237122 First appointment Mar 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2012
Shareholding value •••• Premium profile

About Muskan Karamchandani

Data last updated:

Muskan Karamchandani is a Director at Sellwell Pharmaceuticals Limited (since 2012). The company operates in Pharma. Sellwell Pharmaceuticals Limited reported revenue of ₹27.85 Cr (FY 2024).

DIN 05237122
Primary Designation Director
Industry Pharma
First Appointment 23 Mar 2012
Oldest Company Age 37 yrs
Largest company Sellwell Pharmaceuticals Limited · ₹27.85 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sellwell Pharmaceuticals Limited U24232MP1989PLC005424
Director23 Mar 20121989₹27.85 Cr (FY 2024)Active

Board colleagues of Muskan Karamchandani

Directorship timeline

Open interactive timeline →
Sellwell Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Muskan Karamchandani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muskan Karamchandani

Muskan Karamchandani currently holds 1 directorship: Sellwell Pharmaceuticals Limited (Director, since 23 Mar 2012, revenue ₹27.85 Cr (FY 2024)).

Muskan Karamchandani was first appointed on 23 Mar 2012 as Director at Sellwell Pharmaceuticals Limited.

The current boards of Muskan Karamchandani's companies include Harish Kumar Matlani (Sellwell Pharmaceuticals Limited), Kamal Karamchandani (Sellwell Pharmaceuticals Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available